Pmv Pharmaceuticals, Inc. · NASDAQ:PMVP
Euclidean Capital LLC's stake in Pmv Pharmaceuticals, Inc. fell to 4.90% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Euclidean Capital LLC's stake in Pmv Pharmaceuticals, Inc. fell to 4.90%, 2,627,643 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 2,627,643
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Euclidean Capital LLC | 4.90% | 2,627,643 |
| Marilyn H. Simons | 4.90% | 2,627,643 |
| Ashvin B. Chhabra | 4.90% | 2,627,643 |
| Greenland NFP B Ltd. | 2.40% | 1,300,818 |
| Greenland NFP LLC | 0.10% | 66,300 |
| Greenland A LLC | 0.70% | 346,884 |
| Symmetry Group Ltd. | 0.50% | 247,203 |
Source
Related
- Pmv Pharmaceuticals, Inc.
- Euclidean Capital LLC
- Pmv Pharmaceuticals, Inc. shareholders
- Schedule 13G · Srinivas Akkaraju · Sep 15, 2026
- Schedule 13G/A · Sio Capital Management, LLC · Jul 28, 2026
- Schedule 13G/A · ArrowMark Colorado Holdings LLC · Jul 10, 2026
- Schedule 13G/A · Sio Capital Management, LLC · May 4, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Mar 4, 2026